-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Import duties and VAT / sales tax
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Performance Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
-
Monitoring and Evaluation
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- M&E Components of Grant Implementation
- Monitoring and Evaluation Components of Grant Making
- Overview
- Principal Recipient Start-Up
-
Health Product Management
- UNDP Quality Assurance Policy
- Compliance with the Global Fund requirements
- Distribution
- Inspection and Receipt
- International freight, transit requirements and use of INCOTERMS
- Inventory Management
- Overview - Health Product Management
- Pharmacovigilance
- Product Selection
- Quality monitoring of health products
- Quantification and Forecasting
- Rational use
- Risk Management for PSM of health products
-
Sourcing and regulatory aspects
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Global Health Procurement Center (GHPC)
- Guidance on donations of health products
- Health Procurement Architecture
- Local Procurement of health products
- Other Elements of the UNDP Procurement Architecture
- Procurement of non-pharmaceutical Health Products
- Procurement of Pharmaceutical Products
- Submission of GHPC CO Procurement Request Form
- Storage
- Supply Planning of Health Products
- UNDP Health PSM Roster
- Waste management
- Grant Reporting
-
Risk Management
- Introduction to Risk Management
- Overview
- Risk management in crisis settings
-
Risk Management in the Global Fund
- Additional Safeguard Policy
- Challenging Operating Environment (COE) Policy
- Global Fund Review of Risk Management During Grant Implementation
- Global Fund Risk Management Framework
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Risk Management Requirements for PRs
- Local Fund Agent
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Sub-Recipient Management
Surveillance and monitoring for substandard and falsified medical products
Substandard and falsified (SF) medical products correspond to the following definitions:
- Substandard also called “out of specification”, these are authorized medical products that fail to meet either their quality standards or specifications, or both.
- Falsified medical products that deliberately/fraudulently misrepresent their identity, composition or source.
SF medical products from all main therapeutic categories and from every region of the world have been reported to WHO, including medicines, vaccines and in vitro diagnostics; however, anti-malarials and antibiotics are amongst the most commonly reported SF medical products. Both generic and innovator medical products can be falsified, ranging from very expensive products for cancer to very inexpensive products for management of pain.
Substandard and falsified medical products contribute to antimicrobial resistance and drug-resistant infections. They may cause harm to patients and fail to treat the diseases for which they were intended and they lead to loss of confidence in medicines, healthcare providers and health systems.
To facilitate the reporting and sharing of information on SF medical products, in 2013, WHO launched a Global Surveillance and Monitoring system for SF medical products. The system allows reporting, coordination and technical support and sharing of information between Member States. The system is designed for use by a trained focal point in the NRA.
If UNDP COs discovers or is informed of a suspected or confirmed SF medical products (at reception of supplies or during supervision visits in the field for instance), it should inform the NRA focal point of the Surveillance system and facilitate the transmission of a report to rapidalert[@]who[dot]int. The CO should put the UNDP QA Team in copy in all the communication with the NRA and the WHO Rapid Alert team. WHO will then contact the NRA focal point and provide the adequate support.
It is also advised that one person (who is part of the PSM team in the UNDP CO) is made responsible for receiving the alerts published by the Global Reporting Mechanism, and each time an alert is posted to check if the product concerned has been supplied to UNDP. If the product has been supplied to UNDP, the CO should immediately inform the QA team for further instructions.
Loading resources
